A new cancer treatment that uses a person’s own immune cells has been approved by the U.S. Food and Drug Administration for treating the most dangerous type of skin cancer.
Now this form of cellular therapy (tumor-infiltrating lymphocyte – or TIL therapy) is showing promise in advanced lung cancers through clinical trials underway at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Learn more about cancer care and research at The Ohio State University:
Home: [ Ссылка ]
Blog: [ Ссылка ]
News: [ Ссылка ]
Follow The James on social media:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
